{
    "ticker": "DXCM",
    "name": "Dexcom, Inc.",
    "description": "Dexcom, Inc. is a leading medical device company that specializes in continuous glucose monitoring (CGM) systems for people with diabetes. Established in 1999 and headquartered in San Diego, California, Dexcom has revolutionized diabetes care through its innovative technology that allows for real-time glucose monitoring. Their flagship product, the Dexcom G6, offers patients the ability to monitor their glucose levels continuously and accurately without the need for routine fingersticks. This technology not only improves glucose control but also enhances the quality of life for those managing diabetes. Dexcom\u2019s devices are designed to be user-friendly, integrating seamlessly with smartphones and smartwatches to provide instant alerts and data. The company is committed to advancing diabetes care through continuous innovation, focusing on improvements in technology, connectivity, and user experience. With a strong emphasis on patient-centric solutions, Dexcom aims to empower individuals with diabetes to take control of their health and live fuller lives. The company has also expanded its product offerings to include software applications that provide insights and analytics, further enhancing diabetes management. Dexcom's mission is to help people with diabetes live their best lives by providing them with the tools they need to manage their condition effectively.",
    "industry": [
        "Medical Devices",
        "Healthcare"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "1999",
    "website": "https://www.dexcom.com",
    "ceo": "Kevin Sayer",
    "social_media": {
        "twitter": "https://twitter.com/Dexcom",
        "linkedin": "https://www.linkedin.com/company/dexcom/"
    },
    "investor_relations": "https://investors.dexcom.com",
    "key_executives": [
        {
            "name": "Kevin Sayer",
            "position": "CEO"
        },
        {
            "name": "Jerome B. Zeldis",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Continuous Glucose Monitoring Systems",
            "products": [
                "Dexcom G6",
                "Dexcom G7"
            ]
        },
        {
            "category": "Software Solutions",
            "products": [
                "Dexcom Share",
                "Dexcom Follow"
            ]
        }
    ],
    "seo": {
        "meta_title": "Dexcom, Inc. | Continuous Glucose Monitoring for Diabetes",
        "meta_description": "Learn about Dexcom, Inc., a leader in continuous glucose monitoring systems that empower individuals with diabetes to manage their health more effectively.",
        "keywords": [
            "Dexcom",
            "Continuous Glucose Monitoring",
            "Diabetes Management",
            "Medical Devices",
            "Dexcom G6",
            "Dexcom G7"
        ]
    },
    "faq": [
        {
            "question": "What does Dexcom specialize in?",
            "answer": "Dexcom specializes in continuous glucose monitoring systems for people with diabetes."
        },
        {
            "question": "Who is the CEO of Dexcom?",
            "answer": "Kevin Sayer is the CEO of Dexcom, Inc."
        },
        {
            "question": "Where is Dexcom headquartered?",
            "answer": "Dexcom is headquartered in San Diego, California, USA."
        },
        {
            "question": "What are Dexcom's main products?",
            "answer": "Dexcom's main products include the Dexcom G6 and Dexcom G7 continuous glucose monitoring systems."
        },
        {
            "question": "When was Dexcom founded?",
            "answer": "Dexcom was founded in 1999."
        }
    ],
    "competitors": [
        "ABT",
        "MDT",
        "TNDM"
    ],
    "related_stocks": [
        "AAPL",
        "GOOGL",
        "AMZN",
        "MSFT"
    ]
}